{"nct_id":"NCT07006727","title":"Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors","status":"NOT_YET_RECRUITING","status_verified_date":"2025-09","start_date":"2025-12-17","start_date_type":"ESTIMATED","primary_completion_date":"2031-08-18","primary_completion_date_type":"ESTIMATED","completion_date":"2031-08-18","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["NVS"]}